Skip to content
10-K

Annual Report

BIOADAPTIVES, INC. BDPT

0001640334-26-000718

← back to feed
Filed
Apr 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 12.01M sh
Shares Diluted FY 2025 · Dec 31, 2025 10.07M sh
Shares Diluted FY 2025 · Dec 31, 2024 8.22M sh
Capex FY 2025 · Dec 31, 2025 $18K
Capex FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$516.03K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$249.52K
Cash And Equivalents FY 2025 · Dec 31, 2025 $215.21K
Cash And Equivalents FY 2025 · Dec 31, 2024 $261.89K
Stockholders Equity FY 2025 · Dec 31, 2025 −$2.13M
Stockholders Equity FY 2025 · Dec 31, 2024 −$1.46M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.65M
Current Liabilities FY 2025 · Dec 31, 2025 $2.36M
Current Liabilities FY 2025 · Dec 31, 2024 $1.73M
Total Liabilities FY 2025 · Dec 31, 2025 $2.36M
Total Liabilities FY 2025 · Dec 31, 2024 $1.73M
Current Assets FY 2025 · Dec 31, 2025 $211.9K
Current Assets FY 2025 · Dec 31, 2024 $261.89K
Total Assets FY 2025 · Dec 31, 2025 $225.9K
Total Assets FY 2025 · Dec 31, 2024 $261.89K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.15
Eps Diluted FY 2025 · Dec 31, 2024 −$0.11
Sga Expense FY 2025 · Dec 31, 2025 $820.51K
Sga Expense FY 2025 · Dec 31, 2024 $335.31K
Net Income FY 2025 · Dec 31, 2025 −$1.56M
Net Income FY 2025 · Dec 31, 2024 −$899.16K
Operating Income FY 2025 · Dec 31, 2025 −$1.04M
Operating Income FY 2025 · Dec 31, 2024 −$602.09K
Gross Profit FY 2025 · Dec 31, 2025 $12.5K
Gross Profit FY 2025 · Dec 31, 2024 $4.03K
Cost Of Revenue FY 2025 · Dec 31, 2025 $5.78K
Cost Of Revenue FY 2025 · Dec 31, 2024 $8.64K
Revenue FY 2025 · Dec 31, 2025 $18.28K
Revenue FY 2025 · Dec 31, 2024 $12.67K